Septerna, Inc. (SEPN)
NASDAQ: SEPN · Real-Time Price · USD
36.35
-1.10 (-2.94%)
Oct 16, 2026, 4:00 PM EDT - Market closed
Septerna Revenue
Septerna had revenue of $26.75M in the quarter ending June 30, 2026, with 22,375.63% growth. This brings the company's revenue in the last twelve months to $98.88M, up 13,520.11% year-over-year. In the year 2025, Septerna had annual revenue of $45.95M with 4,174.51% growth. That makes Septerna the 22,724th largest company in the world by revenue and 3,299th in the United States.
Revenue (ttm)
$98.88M
Revenue Growth
+13,520.11%
P/S Ratio
17.16
Revenue / Employee
$803,919
Employees
123
Market Cap
1.70B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 45.95M | 44.88M | 4,174.51% |
| Dec 31, 2024 | 1.08M | 924.00K | 611.92% |
| Dec 31, 2023 | 151.00K | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
SEPN News
- 11 days ago - 3 Small-Cap Stocks Analysts Expect to Rally over 35% - TipRanks
- 5 weeks ago - Septerna, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Septerna Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 5 weeks ago - Septerna Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 6 weeks ago - Septerna to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer - GlobeNewsWire
- 1 month ago - Septerna price target raised to $48 from $38 at JPMorgan - TheFly
- 2 months ago - Septerna price target raised to $60 from $40 at H.C. Wainwright - TheFly